Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.56B | 5.93B | 4.84B | 2.98B | 1.48B | 1.56B |
Gross Profit | 2.53B | 2.69B | 2.39B | 1.35B | 558.99M | 705.26M |
EBITDA | 334.86M | 566.25M | -343.40M | -168.66M | 240.52M | 367.03M |
Net Income | -393.13M | -177.71M | -1.13B | -574.33M | 49.40M | 207.15M |
Balance Sheet | ||||||
Total Assets | 7.95B | 8.15B | 7.69B | 8.67B | 6.64B | 6.55B |
Cash, Cash Equivalents and Short-Term Investments | 2.90B | 1.73B | 2.74B | 3.80B | 3.66B | 5.55B |
Total Debt | 1.86B | 2.05B | 1.40B | 1.50B | 0.00 | 0.00 |
Total Liabilities | 2.75B | 2.95B | 2.55B | 2.59B | 194.63M | 143.50M |
Stockholders Equity | 4.70B | 4.64B | 4.79B | 5.87B | 6.44B | 6.40B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -200.24M | 20.80M | 387.11M | 186.17M | -18.82M |
Operating Cash Flow | 0.00 | 219.03M | 464.00M | 483.38M | 198.15M | 360.70M |
Investing Cash Flow | 0.00 | -479.27M | -1.22B | -144.47M | -2.09B | -384.52M |
Financing Cash Flow | 0.00 | 664.63M | -303.96M | -200.78M | 1.00K | 15.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥11.54B | 19.84 | 1.56% | 27.15% | 24.58% | ||
75 Outperform | ¥14.24B | 18.90 | 0.55% | 12.09% | 141.99% | ||
67 Neutral | ¥14.57B | 122.13 | ― | 21.37% | 33.73% | ||
57 Neutral | HK$14.53B | 9.13 | -0.60% | 4.32% | 7.09% | -37.88% | |
51 Neutral | ¥17.03B | ― | ― | 22.47% | 84.35% | ||
48 Neutral | ¥60.94B | ― | ― | 32.00% | 55.33% | ||
41 Neutral | ¥17.27B | ― | ― | 24.80% | 12.00% |
HEROZ, Inc. reported its consolidated financial results for the fiscal year ended April 30, 2025, showing a 22.5% increase in net sales compared to the previous year, despite a decline in operating and ordinary profits. The company anticipates further growth in the upcoming fiscal year, with projected increases in net sales and profits, indicating a positive outlook for stakeholders.
HEROZ, Inc. announced an extraordinary loss due to impairment in software assets related to its group company, StrategIT, Inc., impacting its financial results for the fiscal year ending April 2025. Despite the loss, the company continues to invest in its product, JOINT iPaaS for SaaS, aiming to leverage its AI expertise and expand its recurring revenue model in the growing SaaS market.